Susquehanna International Group, LLP Aslan Pharmaceuticals LTD Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.74 - $1.22 $13,919 - $22,948	-18,810 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.11 - $1.86 $228,232 - $382,443	-205,615 Reduced 91.62%	18,810 $21,000
Q3 2021 Nov 15, 2021	BUY	$1.78 - $3.41 $399,476 - $765,289	224,425 New	224,425 $399,000
Q4 2020 Feb 16, 2021	SELL	$1.54 - $2.22 $25,111 - $36,199	-16,306 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.41 - $2.04 $22,991 - $33,264	16,306 New	16,306 $31,000
Q2 2020 Aug 14, 2020	SELL	$0.96 - $2.19 $21,854 - $49,855	-22,765 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.93 - $2.8 $10,761 - $32,401	11,572 Added 103.39%	22,765 $23,000
Q4 2019 Feb 14, 2020	BUY	$0.37 - $5.2 $4,141 - $58,203	11,193 New	11,193 $23,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.